Efficacy of extended pirlimycin hydrochloride therapy for treatment of environmental Streptococcus spp and Staphylococcus aureus intramammary infections in lactating dairy cows

Fifty-one chronically infected lactating dairy cows were used to evaluate the efficacy of extended pirlimycin therapy regimens for treatment of intramammary infections by environmental Streptococcus spp and Staphylococcus aureus. Cows (n = 47) with one or more infected mammary quarters were blocked by parity and randomly allocated to one of three groups for treatment with pirlimycin (50 mg/mammary quarter) as follows: one treatment per day for 2 days (n = 36 infected mammary quarters); one treatment per day for 5 days (n = 36 infected mammary quarters); and one treatment per day for 8 days (n = 20 infected mammary quarters). Four cows with nine infected mammary quarters were included as untreated controls. Milk samples from each mammary quarter were collected 7 days before treatment, immediately before treatment, and weekly for 4 weeks after the final treatment for microbiological evaluation. A bacteriologic cure was defined as a treated, infected quarter that was bacteriologically negative for the presence of previously identified bacteria at weekly intervals after treatment. Efficacy of pirlimycin therapy against intramammary infections caused by environmental Streptococcus spp and S. aureus was 44.4%, 61.1%, and 95.0% for the 2-, 5-, and 8-day treatment regimens, respectively. None of the infections in the untreated control quarters was cured. Significant differences in efficacy were detected between all pirlimycin groups and the untreated control group, between the 8- and 2-day treatment regimens, and between the 8-day and 5-day treatment regimens (P < or = .05). Results of this study indicate that extended pirlimycin therapy was effective in eliminating intramammary infections caused by environmental streptococci and S. aureus in lactating dairy cows.     

Transplacental toxoplasmosis in a reindeer (Rangifer tarandus) fetus

Toxoplasma gondii infection was diagnosed in a full term stillborn reindeer (Rangifer tarandus) fetus. The fetus had encephalitis and placentitis associated with T. gondii. Tissue cysts were identified histologically in sections of brain and tachyzoites were present in placenta and the myocardium. Protozoa in the brain, heart, and placenta stained positively with T. gondii antibodies, but not with Neospora caninum antibodies in an immunohistochemical test. The dam of the fetus had a 1:12,800 titer to T. gondii in the modified agglutination test employing whole tachyzoites and mercaptoethanol. This is the first confirmed report of T. gondii infection in reindeer.     

Defining and using behavioral competencies to manage performance and careers: potential applications and implications for veterinary medicine

Recent studies have highlighted concerns regarding the skills, career prospects, and economic prosperity of veterinarians. Human resource departments in a wide variety of organizations and industries have adopted a competency-based approach to managing the selection, training, placement, and ongoing development of their staff. This paper defines competencies, characterizes their typical use in industry, and examines the potential applications of a competency-based approach for veterinary medicine. It is argued that the competency-based approaches honed in the private sector promise to assist veterinary colleges, employers of veterinarians, and professional societies in influencing the state of the profession through the selection, education, and development of veterinarians.     

Effect of hyperbaric oxygen treatment on incorporation of an autogenous cancellous bone graft in a nonunion diaphyseal ulnar defect in cats

OBJECTIVE: To determine whether hyperbaric oxygen treatment (HBOT) would affect incorporation of an autogenous cancellous bone graft in diaphyseal ulnar defects in cats. ANIMALS: 12 mature cats. PROCEDURE: Bilateral nonunion diaphyseal ulnar defects were created in each cat. An autogenous cancellous bone graft was implanted in 1 ulnar defect in each cat, with the contralateral ulnar defect serving as a nongrafted specimen. Six cats were treated by use of hyperbaric oxygen at 2 atmospheres absolute for 90 minutes once daily for 14 days, and 6 cats were not treated (control group). Bone labeling was performed, using fluorochrome markers. Cats were euthanatized 5 weeks after implanting, and barium sulfate was infused to evaluate vascularization of grafts. Ulnas were evaluated by use of radiography, microangiography, histologic examination, and histomorphometric examination. RESULTS: Radiographic scores did not differ between treatment groups. Microangiographic appearance of grafted defects was similar between groups, with all having adequate vascularization. Differences were not observed between treated and nontreated groups in the overall histologic appearance of decalcified samples of tissue in grafted defects. Mean distance between fluorescent labels was significantly greater in cats given HBOT than in nontreated cats. Median percentage of bone formation in grafted defects was significantly greater in cats given HBOT. CONCLUSIONS: Hyperbaric oxygen treatment increased the distance between fluorescent labels and percentage of bone formation when incorporating autogenous cancellous bone grafts in induced nonunion diaphyseal ulnar defects in cats, but HBOT did not affect revascularization, radiographic appearance, or qualitative histologic appearance of the grafts.     

Risk factors affecting the outcome of surgery for atlantoaxial subluxation in dogs: 46 cases (1978-1998)

OBJECTIVE: To identify risk factors for successful surgical management of dogs with atlantoaxial subluxation (AAS). DESIGN: Retrospective study. ANIMALS: 46 dogs managed surgically for AAS. PROCEDURE: Age at onset of clinical abnormalities, duration of clinical abnormalities prior to surgery, radiographic appearance of the dens, type (dorsal or ventral procedure) and number (1 or 2) of surgeries performed, grade of postoperative atlantoaxial joint reduction, and neurologic status prior to surgery (preoperative), when dogs were discharged from the hospital (postoperative), and during a follow-up evaluation (final) were obtained from the dogs' medical records. Risk factors for surgical success and degree of neurologic improvement were identified and analyzed for predictive potential. RESULTS: Age at onset of clinical abnormalities < or = 24 months was significantly associated with greater odds of a successful first surgery and final outcome and a lower postoperative neurologic grade. Duration of clinical abnormalities < or = 10 months was significantly associated with greater odds of a successful final outcome and a lower final neurologic grade. A preoperative neurologic grade of 1 or 2 was significantly associated with a lower final neurologic grade. Potential risk factors that did not affect odds of a successful outcome included type of surgery performed, grade of atlantoaxial joint reduction, radiographic appearance of the dens, or need for a second surgery. CONCLUSIONS AND CLINICAL RELEVANCE: Age at onset of clinical abnormalities, duration of clinical abnormalities prior to surgery, and preoperative neurologic status are risk factors for success of surgical management of AAS in dogs.     

Ultraviolet radiation and laying pullets

1. Responses to ultraviolet (UV) radiation were studied in two trials. In one trial, sexually mature pullets, that had been maintained on an 8L:16D regimen from 2 d of age, were exposed sequentially, for periods of 9 to 12 d, to a further 8 h of very dim visible light (VDV), to 8 h of UV radiation and, finally, to an extra 8 h of normal light (conventional 16L:8D). Individual ovipositions were recorded during the last 48 h of each treatment. In the second trial, sexually mature pullets which had been allowed to 'free-run' for 14 d under continuous normal illumination (LL), were given, in addition to the normal light, a 12-h period of UV radiation commencing at midday or midnight for a further 15 d. During the final 48 h oviposition times were recorded and 4 food intakes for each 12-h period were determined. 2. In trial 1, mean oviposition time under VDV and UV supplementation was not significantly different from that under the 8L:16D regimen. Transfer to a 16L:8D regimen altered mean time of oviposition by about 4 h. In trial 2, eggs continued to be laid almost at random in all groups. 3. Food intake was suppressed during the 12-h period of UV supplementation compared with that when the birds were not receiving UV. 4. It is concluded that the addition of 8 h of UV radiation (at the intensity used in these studies) to 8 h of normal light does not cause a phase shift in the timing of the 'open-period' for pre-ovulatory luteinising hormone release which determines the time of oviposition. Furthermore, the insertion of 12-h periods of UV into continuous illumination does not entrain egg laying. 5. The suppressing effect of UV on food intake but lack of influence on the timing of the ovulatory cycle suggests that UV (at the intensity used in this study) acts principally at the retinal level and, as a result, stimulates only behavioural responses in laying birds.     

Further assessment of the dietary lysine requirement of finishing gilts

A cooperative research study involving 635 gilts was conducted at eight research stations to further estimate the lysine requirement of finishing gilts. Dietary crude protein levels of the five dietary treatments ranged from 16.0 to 24.4% with calculated lysine levels of .80, .95, 1.10, 1.25, or 1.40%. Each station contributed a minimum of two replicate pens of pigs per treatment. Average initial and final weights were 53.6 and 116.4 kg, respectively. At the end of the experimental period, pigs were killed and hot carcass weight, 10th-rib fat depth, and longissimus muscle area were measured. Carcass fat-free lean percentage and fat-free lean gain were estimated from these data. Daily lysine intakes averaged 21.8, 25.9, 30.5, 34.3, and 37.8 g/d for the five treatment groups, respectively. Increasing the dietary lysine from .80 to .95% numerically increased weight gain and gain:feed, but these increases were not maintained at higher levels of dietary lysine. Overall, rate and efficiency of gain decreased (cubic, P < .01) with increasing dietary lysine. Carcasses were leaner at the two higher levels of dietary lysine as evidenced by reduced 10th rib backfat (linear, P < .01), increased longissimus area (quadratic, P < .04), and increased percentage of estimated fat-free lean (linear, P < .01). Carcass fat-free lean gain was not influenced by dietary lysine except for a small numerical improvement (P < .11) at the .95% level of dietary lysine that paralleled the improvement in body weight gain. The results indicate that the dietary lysine requirement of finishing gilts with a mean carcass fat-free lean growth rate of 306 g/d from 54 to 116 kg body weight is probably no higher than .80% of the diet to achieve maximum rate and efficiency of body weight gain and carcass lean growth rate. The results also indicate that higher dietary lysine levels may increase carcass leanness in finishing gilts, possibly due to reduced intake of NE. Whether this response is due to the effects of lysine alone, protein (i.e., other amino acids), or soybean meal is unknown.     

Metabolize methionine and lysine requirements of growing cattle

Two growth studies were conducted to determine the Met and Lys requirements of growing cattle. In each 84-d trial, steer calves were fed individually diets containing 44% sorghum silage, 44% corn cobs, and 12% supplement (DM basis) at an equal percentage of BW. In Trial 1, 95 crossbred steers (251 kg) were supplemented with urea or meat and bone meal (MBM). Incremental amounts of rumen-protected Met were added to MBM to provide 0, .45, .9, 1.35, 3, and 6 g/d metabolizable Met. In Trial 2, 60 steers (210 kg) were supplemented with urea or corn gluten meal (CGM). Incremental amounts of rumen-protected Lys were added to CGM to provide 0, 1, 2, 3, 4, 5, 6, 8, and 10 g/d metabolizable Lys. Supplementation with MBM and CGM increased the supply of metabolizable protein to the animal. Steers fed MBM plus 0 Met gained 49 g/d more than steers fed urea, whereas steers fed CGM plus 0 Lys gained 150 g/d more than steers fed urea. Supplementation of rumen-protected Met and Lys improved ADG in steers fed MBM and CGM, respectively (P < .10). Nonlinear analysis, comparing gain vs supplemental Met and Lys intake, predicted supplemental Met and Lys requirements of 2.9 and .9 g/d, respectively. This amount of additional Met promoted .13 kg/ d gain greater than MBM alone, and this amount of additional Lys promoted .10 kg/d gain greater than the CGM alone. Metabolizable Met and Lys requirements were predicted from Level 1 of NRC (1996) calculated metabolizable protein supply, amino acid analysis of abomasal contents, and the maximum response to supplemental AA. Steers gaining .39 kg/d required 11.6 g/ d Met or 3. 1% of the metabolizable protein requirement, whereas steers gaining .56 kg/d required 22.5 g/d Lys or 5.7% of the metabolizable protein requirement.     

Ability of induced corpora lutea to maintain pregnancy in beef cows

Experiments were conducted in beef cows without a primary CL, in which pregnancy had been maintained with exogenous progestogen. In preliminary trials, replacement CL induced ipsilateral to the embryo and after, rather than before, d 36 of pregnancy, maintained more pregnancies after withdrawal of exogenous progestogen (13/13 vs 2/6; P < 0.05). In Exp. 1, in cows with replacement CL induced by treatment with hCG on d 28 of pregnancy, treatment with flunixin meglumine on d 31 through 37 did not increase maintenance of pregnancy. Experiment 2 was conducted to evaluate directly the effects of concentrations of PGF2alpha and estradiol-17beta during d 31 through 35 of pregnancy on maintenance of pregnancy by replacement CL induced between d 28 and 31. In cows that maintained pregnancy while progestogen was provided, maintenance of pregnancy after withdrawal of exogenous progestogen tended to be greater with high (5/5) than with low (2/6; P < 0.10) concentrations of PGF2alpha and greater with low (6/7) than with high (2/6; P = 0.10) concentrations of estradiol-17beta. Secretion of progesterone by replacement CL was greater (P < 0.05) in cows with high than in those with low concentrations of PGF2, during d 31 through 35. Prostaglandin F2alpha may facilitate attachment of the bovine embryo (d 30 to 40) in a manner similar to that reported for implantation in other species. Cows that did not form CL in response to hCG on d 28 to 31 responded well when retreated after d 36. Again, maintenance of pregnancy was greater when replacement CL were induced after (9/9) rather than before d 36 (8/16; P < 0.05).